Hugo M. Horlings

Citirano

	Sve	Od 2020.
Citati	27873	13340
H-indeks	59	44
i10-indeks	115	103

2800

1400

700

2100

200820092010201120122013201420152016201720182019202020212022202320242025162 401 615 782 1000 1210 1436 1567 1669 1705 1811 1907 2498 2791 2670 2540 2443 390

Javni pristup

Prikaži sve

95 članaka

8 članaka

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Sabine LinnProfessor of Translational Oncology - Utrecht University; Group leader NKI AmsterdamPotvrđena adresa e-pošte na nki.nl
Rene BernardsNetherlands Cancer InstitutePotvrđena adresa e-pošte na nki.nl
fabien reyalInstitut Curie. Department of SurgeryPotvrđena adresa e-pošte na curie.fr
Jelle WesselingGroup Leader, Netherlands Cancer InstitutePotvrđena adresa e-pošte na nki.nl
David HuntsmanBC Cancer AgencyPotvrđena adresa e-pošte na bccancer.bc.ca
Howard Y. ChangChief Scientific Officer, AmgenPotvrđena adresa e-pošte na stanford.edu
Saraswati SukumarProfessor of OncologyPotvrđena adresa e-pošte na jhmi.edu
Anita LangerødResearcher, Oslo University HospitalPotvrđena adresa e-pošte na rr-research.no
Ali BashashatiUniversity of British Columbia/Vancouver Coastal Health Research InstitutePotvrđena adresa e-pošte na bccrc.ca
Sohrab ShahMemorial Sloan Kettering Cancer CenterPotvrđena adresa e-pošte na mskcc.org
Gordon MillsOregon Health & Science UniversityPotvrđena adresa e-pošte na ohsu.edu
Pedram ArganiProfessor of Pathology and Oncology, Johns Hopkins UniversityPotvrđena adresa e-pošte na jhmi.edu
Rachael NatrajanThe Institute of Cancer ResearchPotvrđena adresa e-pošte na icr.ac.uk
Michael S. AnglesioAssistant Professor, Department of Obstetrics & Gynaecology, University of British ColumbiaPotvrđena adresa e-pošte na ubc.ca
Petra M NederlofNetherlands Cancer Institute NKIPotvrđena adresa e-pošte na nki.nl
Manolis KellisProfessor of Computer Science, MIT and Broad InstitutePotvrđena adresa e-pošte na mit.edu
Michael F. Linindependent (mlin.net LLC)Potvrđena adresa e-pošte na mlin.net
Jos JonkersProfessor at Leiden University and group leader at Netherlands Cancer Institute, Oncode InstitutePotvrđena adresa e-pošte na nki.nl
Oscar krijgsmanPrinciple Bioinformatician, Neogene TherapeuticsPotvrđena adresa e-pošte na neogene.com
Joe GrayBiomedical Engineering, Oregon Health and Science UniversityPotvrđena adresa e-pošte na ohsu.edu

Prati

Hugo M. Horlings

MD PhD, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Potvrđena adresa e-pošte na nki.nl - Početna stranica

Molecular pathology therapy resistance oncogenic pathways breast cancer ovarian cancer


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis RA Gupta, N Shah, KC Wang, J Kim, HM Horlings, DJ Wong, MC Tsai, ... nature 464 (7291), 1071-1076, 2010	5899	2010
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer K Berns, HM Horlings, BT Hennessy, M Madiredjo, EM Hijmans, K Beelen, ... Cancer cell 12 (4), 395-402, 2007	1934	2007
AACR Project GENIE: powering precision medicine through an international consortium AACR Project Genie Consortium, AACR Project GENIE Consortium, ... Cancer discovery 7 (8), 818-831, 2017	1484	2017
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters T Hung, Y Wang, MF Lin, AK Koegel, Y Kotake, GD Grant, HM Horlings, ... Nature genetics 43 (7), 621-629, 2011	1380	2011
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer K Stemke-Hale, AM Gonzalez-Angulo, A Lluch, RM Neve, WL Kuo, ... Cancer research 68 (15), 6084-6091, 2008	1233	2008
Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma H Li, AM van der Leun, I Yofe, Y Lubling, D Gelbard-Solodkin, ... Cell 176 (4), 775-789. e18, 2019	969	2019
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas B Kreike, M van Kouwenhove, H Horlings, B Weigelt, H Peterse, ... Breast Cancer Research 9, 1-14, 2007	866	2007
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck M Persson, Y Andrén, J Mark, HM Horlings, F Persson, G Stenman Proceedings of the National Academy of Sciences 106 (44), 18740-18744, 2009	865	2009
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ... Nature medicine 25 (6), 920-928, 2019	819	2019
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311-335, 2017	797	2017
Refinement of breast cancer classification by molecular characterization of histological special types B Weigelt, HM Horlings, B Kreike, MM Hayes, M Hauptmann, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008	727	2008
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (5), 235-251, 2017	698	2017
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators R Mezzadra, C Sun, LT Jae, R Gomez-Eerland, E De Vries, W Wu, ... Nature 549 (7670), 106-110, 2017	639	2017
Cancer-associated mutations in endometriosis without cancer MS Anglesio, N Papadopoulos, A Ayhan, TM Nazeran, M Noë, ... New England Journal of Medicine 376 (19), 1835-1848, 2017	626	2017
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets N Turner, MB Lambros, HM Horlings, A Pearson, R Sharpe, R Natrajan, ... Oncogene 29 (14), 2013-2023, 2010	479	2010
MicroRNA sequence and expression analysis in breast tumors by deep sequencing TA Farazi, HM Horlings, JJ Ten Hoeve, A Mihailovic, H Halfwerk, ... Cancer research 71 (13), 4443-4453, 2011	438	2011
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis LCW Vredeveld, PA Possik, MA Smit, K Meissl, C Michaloglou, ... Genes & development 26 (10), 1055-1069, 2012	328	2012
A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe JWR Hovius, B de Wever, M Sohne, MC Brouwer, J Coumou, ... The Lancet 382 (9892), 658, 2013	317	2013
An acquired vulnerability of drug-resistant melanoma with therapeutic potential L Wang, RL de Oliveira, S Huijberts, E Bosdriesz, N Pencheva, D Brunen, ... Cell 173 (6), 1413-1425. e14, 2018	308	2018
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes YK Wang, A Bashashati, MS Anglesio, DR Cochrane, DS Grewal, G Ha, ... Nature genetics 49 (6), 856-865, 2017	280	2017

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori